Skip to main content

ORIGINAL RESEARCH article

Front. Cardiovasc. Med., 16 December 2022
Sec. Pediatric Cardiology

Nadir oxygen delivery is associated with postoperative acute kidney injury in low-weight infants undergoing cardiopulmonary bypass

\r\nPeng GaoPeng GaoYu JinYu JinPeiyao ZhangPeiyao ZhangWenting WangWenting WangJinxiao HuJinxiao HuJinping Liu
Jinping Liu*
  • Pediatric Cardiac Surgery Center, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Background: Acute kidney injury (AKI) is common after cardiac surgery with cardiopulmonary bypass (CPB) and is associated with increased mortality and morbidity. Nadir indexed oxygen delivery (DO2i) lower than the critical threshold during CPB is a risk factor for postoperative AKI. The critical DO2i for preventing AKI in children has not been well studied. The study aimed to explore the association between nadir DO2i and postoperative AKI in infant cardiac surgery with CPB.

Methods: From August 2021 to July 2022, 413 low-weight infants (≤10 kg) undergoing cardiac surgery with CPB were consecutively enrolled in this prospective observational study. Nadir DO2i was calculated during the hypothermia and rewarming phases of CPB, respectively. The association between nadir DO2i and postoperative AKI was investigated in mild hypothermia (32–34°C) and moderate hypothermia (26–32°C).

Results: A total of 142 (38.3%) patients developed postoperative AKI. In patients undergoing mild hypothermia during CPB, nadir DO2i in hypothermia and rewarming phases was independently associated with postoperative AKI. The cutoff values of nadir DO2i during hypothermia and rewarming phases were 258 mL/min/m2 and 281 mL/min/m2, respectively. There was no significant association between nadir DO2i and postoperative AKI in patients undergoing moderate hypothermia during CPB.

Conclusion: In low-weight infants undergoing mild hypothermia during CPB, the critical DO2i for preventing AKI was 258 mL/min/m2 in the hypothermia phase and 281 mL/min/m2 for rewarming. Moreover, an individualized critical DO2i threshold should be advocated during CPB.

1 Introduction

Acute kidney injury (AKI) is the most common complication in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB), and is associated with increased mortality and morbidity (1, 2). Even mild AKI increases the risk of long-term adverse kidney events (3). Nadir indexed oxygen delivery (DO2i) during CPB is identified as a potentially modifiable risk factor for postoperative AKI (4). Previous observational studies have determined the critical threshold of DO2i to avoid postoperative AKI, in the range of 225–300 mL/min/m2 during CPB (58). Goal-directed perfusion (GDP) aimed to maintain DO2i above a critical threshold during CPB, reducing the incidence of AKI by approximately 50% (9). Moreover, the predictive capacity of DO2i on AKI was validated in an AKI prediction model (10), which was established from a large sample, with a DO2i threshold of 270 mL/min/m2.

About 30–60% of children develop AKI after congenital heart surgery, which is significantly associated with postoperative adverse outcomes (11, 12). Infants may be more susceptible to AKI after pediatric cardiac surgery, for both younger age and lower body weight are independent risk factors (11, 13). However, the critical DO2i for preventing AKI in children has not been well studied, and the published results remain controversial (14, 15). The objective of the present study was to explore the association between nadir DO2i and postoperative AKI in low-weight infants (≤10 kg) undergoing cardiac surgery with CPB.

2 Materials and methods

2.1 Study design and patients

This was a prospective observational study conducted at Fuwai hospital (Beijing, China). From August 2021 to July 2022, every infant scheduled for open-heart cardiac surgery was screened for eligibility. The criteria for selecting the participants were low-weight infants (≤10 kg) undergoing cardiac surgery with an expected CPB duration of 1–3 h (based on surgical complexity). Exclusion criteria were as follows: preoperative complications (chronic kidney disease or central nervous system injury), previous cardiac surgery, expected circulatory arrest during CPB, intraoperative ECMO, repeated CPB, aortic cross-clamping (ACC) duration <30 min or >120 min, and nadir rectal temperature <26°C during CPB.

The study has been approved by the Medical Ethics committee of Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (Approval number: 2021-1483). Written informed consent was obtained from the legal guardian of every enrolled subject. This study followed STROBE reporting guidelines.

2.2 Data collection and definitions

The following variables were collected. Preoperative data: patient demographics and baseline laboratory tests, including Hb, serum creatinine (SCr), and blood urea nitrogen (BUN). Intraoperative data: type of surgery, European Association for Cardiothoracic Surgery-Society of Thoracic Surgeons (STS–EACTS) categories, CPB duration, ACC duration, volume of RBC consumption (including RBC added in CPB priming), and nadir DO2i in the hypothermia and rewarming phases of CPB. DO2i was calculated manually following the formula: DO2i (mL/min/m2) = indexed pump flow (L/min/m2) × [1.36 × Hb (g/L) × Hb saturation (%) + 0.031 × partial pressure of arterial oxygen (mmHg)]. The blood gas analysis was routinely monitored at the following time points: after cardioplegia, every 30 min during ACC, at rewarming, and aortic unclamping. Postoperative variables collected included: duration of mechanical ventilation (MV), length of stay (LOS) in PICU, hospital LOS, AKI, and in-hospital adverse events. In addition, after weaning from CPB, plasma-free hemoglobin (pFHb) was measured using the Plasma/Low Hb Photometer (HemoCue AB, Ängelholm, Sweden).

In view of the correlation between body temperature and oxygen metabolism, patients were divided into mild hypothermia (32–34°C) and moderate hypothermia (26–32°C) according to the lowest rectal temperature. We determined postoperative AKI by the Kidney Disease Improving Global Outcomes (KDIGO) criteria (16). Severe hemolysis after CPB was defined as pFHb > 500 mg/L (17).

2.3 Clinical practice

General anesthesia was performed under the standard protocol of the institution. The standard CPB circuit consists of a roller pump (Stockert S5, Sorin, Germany), a hollow fiber membrane oxygenator (Fx05, Terumo, Japan), and a hemofilter (Maquet BC20, Hirrlingen, Germany). The priming volume of the pump circuit was approximately 200 mL, including Acetated Ringer’s solution, packed red blood cells (RBC), Gelofusine, and sodium bicarbonate. According to the expected CPB duration, patients were treated with modified St Thomas solution or histidine-tryptophan-ketoglutarate solution for cold cardioplegia. The target hypothermia was determined by the surgical complexity and reflux from collateral arteries during CPB.

All patients received arterial pump flow based on body weight and temperature, with a target value of 100–150 mL/kg/min during the hypothermia phase, and 120–180 mL/kg/min during the rewarming phase. Mean arterial pressure was maintained at 30–50 mmHg, and the lowest hemoglobin (Hb) threshold was 70 g/L during CPB. Patients were rewarming to the nasopharyngeal temperature above 36°C with a satisfactory hemodynamic state before weaning from CPB. Modified ultrafiltration (MUF) was routinely carried out to reach Hb > 100 g/L. After the operation, all patients were transferred to the pediatric intensive care unit (PICU).

2.4 Statistical analysis

The normal distribution of variables was assessed visually through Q-Q diagram and histogram. Continuous normal distribution variables were presented as mean ± standard deviation, and median with interquartile ranges for non–normally distributed variables, and were compared using the T-test or Mann–Whitney U test. Categorical variables were expressed as frequencies and percentages, and the Chi-square test or Fisher’s exact test was used for comparisons.

In order to explore the association between nadir DO2i and AKI, the following analysis was performed in patients with mild hypothermia and moderate hypothermia during CPB, respectively. Receiver operating characteristic (ROC) curve analysis was used to determine the predictive performance of hypothermia and rewarming nadir DO2i for postoperative AKI, and the cutoff value, sensitivity, and specificity were reported. Univariable and multivariable logistic regression was used to determine the effect of hypothermia and rewarming nadir DO2i on postoperative AKI. According to the risk factors associated with AKI in pediatric cardiac surgery, the following adjustment factors were selected: age, weight, baseline SCr, STS–EACTS categories, CPB duration, and pFHb (13, 18).

All statistical analyses were performed using SPSS 25.0 and R 4.1.0, and a p-value < 0.05 was considered statistically significant.

3 Results

3.1 Study population

From August 2021 to July 2022, a total of 413 patients were enrolled. 42 patients were excluded, including intraoperative ECMO (n = 1), repeated CPB (n = 7), ACC duration <30 min or >120 min (n = 19), and nadir temperature < 26°C (n = 15). Finally, 371 patients were included in the analysis. Among them, 218 (58.8%) patients underwent mild hypothermia and 153 (41.2%) patients underwent moderate hypothermia during CPB (Figure 1).

FIGURE 1
www.frontiersin.org

Figure 1. Flow chart of the study.

Baseline characteristics of the patients included were demonstrated in Table 1. According to KDIGO criteria, 142 (38.3%) patients developed AKI after surgery.

TABLE 1
www.frontiersin.org

Table 1. Baseline characteristics of the patients.

The differences between groups showed that AKI patients had lower BSA, body length, baseline SCr, and Hb. There was no significant difference in STS–EACTS categories of cardiac surgery. The types of surgery were also shown in Table 1.

3.2 Intraoperative data and clinical outcomes

Patients who developed AKI had lower nadir DO2i during the hypothermic phase (p = 0.034) and rewarming phase (p < 0.001) of CPB. The nadir temperature of AKI patients was lower albeit it was not statistically significant (30.98 ± 1.13 vs 31.20 ± 1.05, p = 0.064). There was no significant difference in other intraoperative data between the two groups, including duration of CPB and ACC, RBC consumption, and pFHb after CPB. Patients with AKI experienced prolonged MV (p = 0.014). There was no significant difference in PICU LOS, hospital LOS, and postoperative adverse events between patients with and without AKI (Table 2).

TABLE 2
www.frontiersin.org

Table 2. Intraoperative data and clinical outcomes.

3.3 Nadir DO2i in hypothermic and rewarming phase

According to the lowest rectal temperature, patients were divided into mild hypothermia (32–34°C) and moderate hypothermia (26–32°C). In patients undergoing mild hypothermia, nadir DO2i was significantly decreased, whether in the hypothermia or rewarming phase of CPB. However, these differences were not significant in patients with moderate hypothermia during CPB (Figure 2).

FIGURE 2
www.frontiersin.org

Figure 2. Hypothermic and rewarming nadir indexed oxygen delivery (DO2i) in mild and moderate hypothermia. NS, not significant (p > 0.05); **p < 0.01; ***p < 0.001.

To assess the predictive performance of nadir DO2i for AKI, ROC curve analysis was conducted in patients undergoing mild hypothermia (Figure 3A) and moderate hypothermia (Figure 3B) during CPB, respectively. In patients undergoing mild hypothermia during CPB, hypothermia nadir DO2i had an AUC of 0.64 (95% CI 0.57–0.70, p < 0.001), with a cutoff value of 258 mL/min/m2 (sensitivity 64.6% and specificity 61.2%). The better predictor was rewarming nadir DO2i, which had an AUC of 0.65 (95% CI 0.59–0.72, p < 0.001), with a cut-off value of 281 mL/min/m2 (sensitivity 64.6% and specificity 64.0%). In patients undergoing moderate hypothermia during CPB, neither hypothermia nadir DO2i (p = 0.348) nor rewarming nadir DO2i (p = 0.086) showed predictive performance for postoperative AKI (Table 3).

FIGURE 3
www.frontiersin.org

Figure 3. Receiver operating characteristic (ROC) curve of nadir DO2i in hypothermic and rewarming phases for postoperative AKI. (A) Patients undergoing mild hypothermia during CPB. (B) Patients undergoing moderate hypothermia during CPB.

TABLE 3
www.frontiersin.org

Table 3. Receiver operating characteristic (ROC) curve of nadir DO2i in hypothermic and rewarming phases for postoperative AKI.

Considering the correlation between nadir DO2i and postoperative AKI in patients undergoing mild hypothermia during CPB, we further evaluated the association using univariable and multivariable logistic regression. The relationship between postoperative AKI and nadir DO2i during the hypothermia and rewarming phases was shown in Figure 4.

FIGURE 4
www.frontiersin.org

Figure 4. Relationship between postoperative AKI and nadir DO2i during the hypothermic and rewarming phases.

As shown in Table 4, after adjusting age, weight, baseline SCr, STS–EACTS categories, CPB duration, and pFHb in multivariable analysis, nadir DO2i during hypothermia and rewarming phases was associated with postoperative AKI, respectively (p = 0.001). When both the hypothermia and rewarming nadir DO2i were brought into logistic regression using a backward stepwise variable selection, the latter remained in the final model. Rewarming nadir DO2i also demonstrated a higher prediction probability in univariable analysis (ROC-AUC: 0.653 vs 0.637). When nadir DO2i was converted into categorical variables according to the cutoff values, hypothermia nadir DO2i < 258 mL/min/m2 (OR 3.012, 95%CI 1.635–5.548, p < 0.001) and rewarming nadir DO2i < 281 mL/min/m2 (OR 3.246, 95%CI 1.767–5.963, p < 0.001) were independent risk factors for postoperative AKI (Table 4). Moreover, in patients undergoing moderate hypothermia, hypothermia nadir DO2i (p = 0.324) and rewarming nadir DO2i (p = 0.069) were not associated with postoperative AKI.

TABLE 4
www.frontiersin.org

Table 4. Univariable and multivariable analysis of nadir DO2i and AKI in patients undergoing mild hypothermia.

3.4 Correlation between nadir DO2i and pFHb after CPB

After weaning from CPB, 108 (29.1%) patients developed severe hemolysis (pFHb > 500 mg/L). Hypothermia and rewarming nadir DO2i were comparable between patients with or without severe hemolysis (Supplementary Table 1). There was no correlation between pFHb and nadir DO2i in patients undergoing mild or moderate hypothermia during CPB (Supplementary Table 2).

4 Discussion

In this study, we demonstrated that nadir DO2i during CPB was associated with postoperative AKI in low-weight infants undergoing mild hypothermia cardiac surgery. The critical DO2i for preventing AKI was 258 mL/min/m2 during the hypothermia phase and 281 mL/min/m2 for rewarming. In contrast, rewarming nadir DO2i was a slightly better predictor of postoperative AKI. In addition, there was no significant association between nadir DO2i and postoperative AKI in patients undergoing moderate hypothermia during CPB.

The association between DO2i during CPB and AKI is one of the hot topics in cardiac surgery. Previous retrospective studies determined that the critical DO2i for avoiding AKI was approximately 270 mL/min/m2 in adults (6, 7, 10). Subsequently, GDP management aimed at maintaining the DO2i level above the specific critical threshold was proposed (19). A meta-analysis of existing research suggested that GDP based on active DO2i management effectively reduced the incidence of AKI after cardiac surgery (9). As a simple and effective management strategy, the application of GDP during CPB was recommended in the recent clinical practice guidelines (4).

Compared with adults, pediatric cardiac surgery is highly heterogeneous in terms of surgical complexity and physiological characteristics. A general threshold of DO2i might not apply to different types of children, such as newborns, infants and preschoolers (15). Bojan and his colleagues indicated that 340 mL/min/m2 was the lowest suitable DO2i for neonates to maintain aerobic metabolism during normothermic CPB (20). However, the primary endpoint of this study was hyperlactatemia after aortic clamping, which was of limited value in preventing postoperative AKI. Zhang et al. (14) reported that the threshold of DO2i of children should be higher than that in adults because of the higher metabolic rate. They recommended a critical value of 353 mL/min/m2 to prevent postoperative AKI. However, the threshold of 353 mL/min/m2 was significantly higher than that of our clinical practice. Therefore, we published correspondence (15) and conducted this prospective observational study. The enrolled subjects were low-weight infants like their study, because these patients have the same CPB circuit composition and management strategy, and are more susceptible to postoperative AKI (11, 13).

The most likely explanation for the disparity in nadir DO2i was the differences in CPB management strategy, which were mainly reflected in the two important parameters in the calculation formula of DO2i: Hb and pump flow rate. In recent years, our institution has adopted restrictive patient blood management to minimize allogeneic RBC transfusion. Previous literature has proved the safety of the conservative transfusion strategy with a Hb threshold of 70 g/L during CPB (21). Additionally, we adopted a miniaturized CPB circuit to matched the blood conservation strategy and correspondingly reduced pump flow rates. Intraoperative oxygen delivery-consumption balance was ensured by monitoring mean arterial pressure, mixed venous oxygen saturation, regional cerebral oxygen saturation, lactate, and urine output. A recent study also indicated that while maintaining normal hemodynamic and metabolic parameters, reducing pump flow would not damage renal function and in-hospital outcomes (22). As a cardiac center that performs more than 4,000 pediatric cardiac surgery every year, our current standard CPB protocol has been tested through years of clinical practice. The incidence of postoperative AKI in our patients (38.3%) was comparable to previous reports (14, 23), even though our subjects were low-weight infants.

Different from previous studies (14, 20), we analyzed the nadir DO2i during hypothermia and rewarming phases, respectively. This allowed better differentiation of the nadir DO2i during the whole CPB period, and thus better matched the actual dynamic flow management. The importance of rewarming DO2i should be emphasized because the rewarming phase had greater risk of medullary hypoxia and AKI (24, 25). Even with high oxygen delivery during hypothermia, microcirculatory perfusion disturbances-induced impaired oxygen consumption would cause oxygen debt (26, 27). In contrast, during the rewarming phase, increasing oxygen delivery levels might recruit and perfuse more vascular beds (28, 29).

In our CPB circuit, it is difficult to provide the same flow rate as that in Zhang et al.’s research (2.8 ∼ 3.2 L/min/m2) (14) at a safe fluid level in the oxygenator and appropriate pump pressure. Because of the concern that high DO2i might lead to increased blood destruction, we measured pFHb after weaning from CPB to partially represent the degree of blood destruction. However, there was no correlation between nadir DO2i and pFHb. This might suggest that there would be no difference in blood destruction under CPB management strategies based on different critical DO2i values. Generally, CPB circuits were similar in adults, while pediatric CPB circuits had various components and corresponding management strategies in different institutions, including the management of hematocrit, body temperature and pump flow rate. Applying a general pediatric DO2i threshold such as 350 mL/min/m2 across different institutions is unrealistic in many cases. Therefore, pediatric GDP based on DO2i might not have to follow a fixed protocol. Under the strategy of evidence-based CPB management, pediatric GDP based on actual clinical practice would benefit the patient.

There were some limitations. Firstly, our study was a prospective observational design with no intervention. Further well-designed randomized controlled trials are needed to determine the effect of DO2i-based GDP on preventing postoperative AKI in pediatric cardiac surgery. Additionally, as DO2i was not continuously monitored, the nadir DO2i analyzed might not be the actual lowest value. Nevertheless, our results are still helpful for most institutions where continuous DO2i monitoring is not available.

5 Conclusion

In low-weight infants undergoing mild hypothermia during CPB, nadir DO2i was associated with postoperative AKI. The critical DO2i for preventing AKI was 258 mL/min/m2 during the hypothermia phase and 281 mL/min/m2 for rewarming. It should be highlighted that higher oxygen delivery might be required during rewarming phase to avoid hypoxia and hypoperfusion. The critical DO2i threshold during CPB to prevent postoperative AKI should be individualized according to institutional clinical practice.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The studies involving human participants were reviewed and approved by the Medical Ethics Committee of Fuwai Hospital. Written informed consent to participate in this study was provided by the participants’ legal guardian/next of kin.

Author contributions

PG, YJ, PZ, WW, JH, and JL contributed to the conception and design of the study. PG, JH, and YJ organized the database. PG and PZ performed the statistical analysis. PG wrote the first draft of the manuscript. JH and JL revised the manuscript. All authors contributed to the manuscript revision, read, and approved the submitted version.

Funding

This study was supported by the CAMS Innovation Fund for Medical Sciences (CIFMS) (project number: 2020-I2M-C&T-B-063).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcvm.2022.1020846/full#supplementary-material

References

1. Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. (2017) 13:697–711. doi: 10.1038/nrneph.2017.119

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Massoth C, Zarbock A, Meersch M. Acute kidney injury in cardiac surgery. Crit Care Clin. (2021) 37:267–78. doi: 10.1016/j.ccc.2020.11.009

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Priyanka P, Zarbock A, Izawa J, Gleason TG, Renfurm RW, Kellum JA. The impact of acute kidney injury by serum creatinine or urine output criteria on major adverse kidney events in cardiac surgery patients. J Thorac Cardiovasc Surg. (2021) 162:143–51.e7. doi: 10.1016/j.jtcvs.2019.11.137

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Peng K, McIlroy DR, Bollen BA, Billings FT, Zarbock A, Popescu WM, et al. Society of cardiovascular anesthesiologists clinical practice update for management of acute kidney injury associated with cardiac surgery. Anesth Analg. (2022) 135:744–56. doi: 10.1213/ANE.0000000000006068

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Magruder JT, Dungan SP, Grimm JC, Harness HL, Wierschke C, Castillejo S, et al. Nadir oxygen delivery on bypass and hypotension increase acute kidney injury risk after cardiac operations. Ann Thorac Surg. (2015) 100:1697–703. doi: 10.1016/j.athoracsur.2015.05.059

PubMed Abstract | CrossRef Full Text | Google Scholar

6. de Somer F, Mulholland JW, Bryan MR, Aloisio T, Van Nooten GJ, Ranucci M. O2 delivery and CO2 production during cardiopulmonary bypass as determinants of acute kidney injury: time for a goal-directed perfusion management? Crit Care. (2011) 15:R192. doi: 10.1186/cc10349

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Ranucci M, Romitti F, Isgrò G, Cotza M, Brozzi S, Boncilli A, et al. Oxygen delivery during cardiopulmonary bypass and acute renal failure after coronary operations. Ann Thorac Surg. (2005) 80:2213–20. doi: 10.1016/j.athoracsur.2005.05.069

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Carrasco-Serrano E, Jorge-Monjas P, Muñoz-Moreno MF, Gómez-Sánchez E, Priede-Vimbela JM, Bardají-Carrillo M, et al. Impact of oxygen delivery on the development of acute kidney injury in patients undergoing valve heart surgery. J Clin Med. (2022) 11:3046. doi: 10.3390/jcm11113046

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Gao, P, Liu J, Zhang P, Bai L, Jin Y, Li Y. Goal-directed perfusion for reducing acute kidney injury in cardiac surgery: a systematic review and meta-analysis. Perfusion. (2022) doi: 10.1177/02676591211073783 [Epub ahead of print].

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Newland RF, Baker RA, Woodman RJ, Barnes MB, Willcox TW, Australian and New Zealand Collaborative Perfusion Registry. Predictive capacity of oxygen delivery during cardiopulmonary bypass on acute kidney injury. Ann Thorac Surg. (2019) 108:1807–14. doi: 10.1016/j.athoracsur.2019.04.115

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Khuong JN, Wilson TG, Iyengar AJ, d’Udekem Y. Acute and chronic kidney disease following congenital heart surgery: a review. Ann Thorac Surg. (2021) 112:1698–706. doi: 10.1016/j.athoracsur.2020.10.054

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Zappitelli M, Parikh CR, Kaufman JS, Go AS, Kimmel PL, Hsu C-Y, et al. Acute kidney injury and risk of CKD and hypertension after pediatric cardiac surgery. Clin J Am Soc Nephrol. (2020) 15:1403–12. doi: 10.2215/CJN.00150120

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Van den Eynde J, Delpire B, Jacquemyn X, Pardi I, Rotbi H, Gewillig M, et al. Risk factors for acute kidney injury after pediatric cardiac surgery: a meta-analysis. Pediatr Nephrol. (2022) 37:509–19. doi: 10.1007/s00467-021-05297-0

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Zhang Y, Wang B, Zhou X-J, Guo L-J, Zhou R-H. Nadir oxygen delivery during pediatric bypass as a predictor of acute kidney injury. Ann Thorac Surg. (2022) 113:647–53. doi: 10.1016/j.athoracsur.2021.01.026

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Gao P, Liu J. Pediatric goal-directed perfusion: is there a general target? Ann Thorac Surg. (2022) 113:1052–3. doi: 10.1016/j.athoracsur.2021.02.074

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Madsen NL, Goldstein SL, Frøslev T, Christiansen CF, Olsen M. Cardiac surgery in patients with congenital heart disease is associated with acute kidney injury and the risk of chronic kidney disease. Kidney Int. (2017) 92:751–56. doi: 10.1016/j.kint.2017.02.021

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Dufour N, Radjou A, Thuong M. Hemolysis and plasma free hemoglobin during extracorporeal membrane oxygenation support: from clinical implications to laboratory details. ASAIO J. (2020) 66:239–46. doi: 10.1097/MAT.0000000000000974

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Hu J, Rezoagli E, Zadek F, Bittner EA, Lei C, Berra L. Free hemoglobin ratio as a novel biomarker of acute kidney injury after on-pump cardiac surgery: secondary analysis of a randomized controlled trial. Anesth Analg. (2021) 132:1548–58. doi: 10.1213/ANE.0000000000005381

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Ranucci M, Johnson I, Willcox T, Baker RA, Boer C, Baumann A, et al. Goal-directed perfusion to reduce acute kidney injury: a randomized trial. J Thorac Cardiovasc Surg. (2018) 156:1918.e–27.e. doi: 10.1016/j.jtcvs.2018.04.045

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Bojan M, Gioia E, Di Corte F, Berkia I, Tourneur T, Tourneur L, et al. Lower limit of adequate oxygen delivery for the maintenance of aerobic metabolism during cardiopulmonary bypass in neonates. Br J Anaesth. (2020) doi: 10.1016/j.bja.2019.12.034 [Epub ahead of print].

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Goel R, Cushing MM, Tobian AAR. Pediatric patient blood management programs: not just transfusing little adults. Transfus Med Rev. (2016) 30:235–41. doi: 10.1016/j.tmrv.2016.07.004

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Abbasciano RG, Hoxha S, Gaburro D, Surdo S, Menon T, Gottin L, et al. Impact on renal function and hospital outcomes of an individualized management of cardiopulmonary bypass in congenital heart surgery: a pilot study. Pediatr Cardiol. (2021) 42:1862–70. doi: 10.1007/s00246-021-02680-4

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Li D, Niu Z, Huang Q, Sheng W, Wang T. A meta-analysis of the incidence rate of postoperative acute kidney injury in patients with congenital heart disease. BMC Nephrol. (2020) 21:350. doi: 10.1186/s12882-020-02005-2

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Evans RG, Lankadeva YR, Cochrane AD, Marino B, Iguchi N, Zhu MZL, et al. Renal haemodynamics and oxygenation during and after cardiac surgery and cardiopulmonary bypass. Acta Physiol (Oxf). (2018) 222. doi: 10.1111/apha.12995

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Boodhwani M, Rubens FD, Wozny D, Nathan HJ. Effects of mild hypothermia and rewarming on renal function after coronary artery bypass grafting. Ann Thorac Surg. (2009) 87:489–95. doi: 10.1016/j.athoracsur.2008.10.078

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Dekker NM, Veerhoek D, Koning NJ, van Leeuwen ALI, Elbers PWG, van den Brom CE, et al. Postoperative microcirculatory perfusion and endothelial glycocalyx shedding following cardiac surgery with cardiopulmonary bypass. Anaesthesia. (2019) 74:609–18. doi: 10.1111/anae.14577

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Krispinsky LT, Stark RJ, Parra DA, Luan L, Bichell DP, Pietsch JB, et al. Endothelial-dependent vasomotor dysfunction in infants after cardiopulmonary bypass. Pediatr Crit Care Med. (2020) 21:42–9. doi: 10.1097/PCC.0000000000002049

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Parolari A, Alamanni F, Gherli T, Bertera A, Dainese L, Costa C, et al. Cardiopulmonary bypass and oxygen consumption: oxygen delivery and hemodynamics. Ann Thorac Surg. (1999) 67:1320–7. doi: 10.1016/s0003-4975(99)00261-1

CrossRef Full Text | Google Scholar

29. Long C, Hu X, Zhang J, Xiu R, Guan Y. Changes of microvascular vasomotion and oxygen metabolism during cooling and rewarming period of cardiopulmonary bypass. J Extra Corpor Technol. (2003) 35:13–6.

PubMed Abstract | Google Scholar

Keywords: acute kidney injury, cardiopulmonary bypass, cardiac surgery, infants, oxygen delivery

Citation: Gao P, Jin Y, Zhang P, Wang W, Hu J and Liu J (2022) Nadir oxygen delivery is associated with postoperative acute kidney injury in low-weight infants undergoing cardiopulmonary bypass. Front. Cardiovasc. Med. 9:1020846. doi: 10.3389/fcvm.2022.1020846

Received: 16 August 2022; Accepted: 02 December 2022;
Published: 16 December 2022.

Edited by:

Zhou Qing, Nanjing Drum Tower Hospital, China

Reviewed by:

Paul Philipp Heinisch, German Heart Centre Munich, Germany
Shijun Xu, Capital Medical University, China

Copyright © 2022 Gao, Jin, Zhang, Wang, Hu and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jinping Liu, bGl1amlucGluZ0BmdXdhaS5jb20=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.